Los Angeles, CA – When the U.S. Food and Drug Administration (FDA) warned of a rare, flesh-eating genital infection linked to a popular class of diabetes drugs, MedTruth embarked on campaign to inform patients about the risk.
MedTruth, a patient safety organization, is currently working to raise awareness about Fournier’s gangrene, a dangerous condition that may affect diabetics taking certain medications. Also known as necrotizing fasciitis of the perineum, Fournier’s gangrene is a painful, genital gangrene caused by untreated infection and reduced blood flow.
The FDA warning, issued in Aug. 2018, linked Fournier’s gangrene to sodium-glucose cotransporter-2 (SGLT2) inhibitors, a commonly used class of diabetes drugs. SGLT2 inhibitors help to manage diabetes by depositing excess glucose through urine. SGLT2 inhibitors include brand-name medications Invokana, Jardiance, Glyxambi and others. Many of these same medications have also been linked to an increased risk of limb amputation among diabetics.
As a consumer health-oriented platform, MedTruth strives to alert patients about serious medical concerns. MedTruth encourages individuals with diabetes to stay vigilant and watch for signs of Fournier’s gangrene in the groin and pelvic regions.
The first signs of Fournier’s gangrene may include pain, tenderness and swelling. Symptoms may develop into a fever and unpleasant odor, which can worsen quickly. Individuals experiencing these conditions should seek medical attention immediately.
With a commitment to informing and educating the public about health hazards, MedTruth has become a voice for patient rights in a manufacturer-controlled market. As rare medical complications caused by pharmaceuticals remain under-reported, patient recognition of conditions like Fournier’s gangrene is more important than ever.
Diabetic patients and the elderly, specifically those with vulnerable immune symptoms, are more likely to develop rare but serious Fournier’s gangrene. Reports show Fournier’s gangrene occurs most frequently in men over the age of 50, but women and children may also develop the condition.
MedTruth strives to ensure each patient has access to the latest resources and information, which can save them from serious medical dangers. As part of their commitment to staying ahead of the latest information in the health and medical world, MedTruth directs patients to stay updated on articles that outline the complications, including the recent publication of “FDA Warns of Rare Genital Gangrene Linked to SGLT2 Diabetes Drugs.”
MedTruth is currently asking diabetes patients who developed Fournier’s gangrene while taking SGL2 inhibitors to share their story. Advocates also encourage diabetes patients taking SGLT2 inhibitors to submit a contact form and ask questions about Fournier’s gangrene.
“We at MedTruth believe it is your right to know about potential drug dangers,” according to MedTruth’s digital mission statement. “We make sourcing simple by going through mounds of data to give you enough information to prevent future complications. We also have the right resources for the millions of Americans who may have been affected by the side effects of drugs and devices.”
MedTruth has built an online community of trusted advocates, along with a team of legal partners who care deeply about consumers. Brimming with the commitment to expose and uncover the truth about dangerous drugs and devices while bringing updated and in-depth information to consumers, MedTruth has become an important patient safety platform sharing knowledge and seeking justice for consumers.
To help millions of Americans stay safe, MedTruth has compiled a list of harmful and hazardous drugs and devices, including the recently flagged Fournier’s Gangrene SGLT2, to help consumers identify potential medical dangers. The comprehensive guides at MedTruth begin with the basics, deliver data summaries, and provide rundowns of recent regulations. These guides can be accessed via www.medtruth.com.
MedTruth is located at 811 W. 7th Street 12th Floor, Los Angeles, CA 90017. For inquiries, contact them via phone at (888) 995-2407 or via email at [email protected]. Visit the website for additional information.
Media ContactCompany Name: MedTruthContact Person: John Smith Email: Send EmailPhone: (888) 995-2407Address:811 W. 7th Street 12th Floor City: Los Angeles State: CaliforniaCountry: United StatesWebsite: medtruth.com/
